PetMed ExpressPETS -0.56%56 Net Margin % is -9.48% as of Mar. 2026. GuruFocus rates PETS with a GF Score™ of 56/100 and a GF Value™ of $2.87 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 668 Healthcare Providers & Services companies, PetMed Express ranks worse than 83.23% on this metric.
Net margin is calculated as Net Income divided by its Revenue. PetMed Express's Net Income for the
three
months ended in Mar. 2026 was $-4.1 Mil. PetMed Express's Revenue for the
three
months ended in Mar. 2026 was $42.8 Mil. Therefore, PetMed Express's net margin for the quarter that ended in Mar. 2026 was -9.48%.
The historical rank and industry rank for PetMed Express's Net Margin % or its related term are showing as below:
PETS'
s Net Margin % Range Over the Past 10 Years
Min: -32 Med: 7.38 Max: 13.62
Current: -32
PETS's Net Margin % is ranked worse than 83.23% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 2.885
vs PETS: -32.00
PetMed Express (NAS:PETS) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
PetMed Express Net Margin % Related Terms
PetMed Express Net Margin % Historical Data
* Premium members only.
The historical data trend for PetMed Express's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, PetMed Express's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PetMed Express Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PetMed Express's Net Margin % distribution charts can be found below:
* The bar in red indicates where PetMed Express's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PetMed Express (PETS) has a Net Margin % of -9.48% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on PetMed Express and its competitors. According to the industry distribution chart, PetMed Express ranks #556 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 83.2%.
Is PetMed Express' Net Margin % too high?
PetMed Express' current Net Margin % is -9.48%. Based on the distribution chart, PetMed Express ranks #556 out of 668 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, PetMed Express has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PetMed Express' Net Margin % compare to BHIC and SHFH?
According to the Healthcare Providers & Services industry distribution chart, PetMed Express ranks #556 out of 668 companies for Net Margin %. This places PetMed Express in the lower half of its industry. The industry median Net Margin % is 2.89. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.89, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on PetMed Express and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PetMed Express's current Net Margin % is -9.48%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PetMed Express stock overvalued right now?
Based on GuruFocus' analysis, PetMed Express (PETS) is currently considered Possible Value Trap. The stock's GF Value™ is $2.87, compared to a current price of $1.76 — trading 38.7% below its estimated fair value. The current Net Margin % is -9.48%. PetMed Express' overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For PetMed Express (PETS), the current Net Margin % is -9.48% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PetMed Express (PETS) Overvalued in 2026?
Based on GuruFocus' analysis, PetMed Express stock appears to be undervalued.
The current stock price of $1.76 is trading 38.7% below its estimated GF Value™ of $2.87.
GuruFocus considers PetMed Express to be Possible Value Trap.
Key valuation signals for PETS:
Net Margin %: -9.48%
GF Value™: $2.87 vs. price of $1.76 (38.7% below fair value)
No single metric tells the full story. See the PETS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.
56GF Score
Get the complete analysis for PETS
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PETS has been successfully added to your 
